All articles tagged: Malignant neoplasm of cervix uteri, unspecified (C53.9)
HealthDay
28 June at 03.02 PM
Survival Improves With Open Hysterectomy for Cervical CancerFor patients with early-stage cervical cancer, disease-free and overall survival are lower for patients undergoing minimally invasive versus open radical hysterectomy, according to a study published online June 25 in the Journal of Clinical Oncology.Pedro T. Ramirez, M.D., from the Methodist Hospital in Houston, and colleagues compared |
|
HealthDay
05 January at 04.32 PM
Atezolizumab Plus Standard Care Improves Survival in Advanced Cervical CancerFor patients with metastatic, persistent, or recurrent cervical cancer, adding atezolizumab to a standard bevacizumab plus platinum regimen significantly improves progression-free and overall survival, according to a study published in the January issue of The Lancet.Ana Oaknin, M.D., from the Vall d'Hebron Institute of Oncology in Barce |
|
HealthDay
30 November at 04.48 PM
Active Surveillance Tied to Higher Long-Term Cervical Cancer RiskUndergoing active surveillance for cervical intraepithelial neoplasia grade 2 (CIN2) is associated with higher long-term risk for cervical cancer compared with that seen for women receiving immediate treatment, according to a study published online Nov. 29 in The BMJ.Kathrine Dyhr Lycke, from Aarhus University in Denmark, and col |
|
HealthDay
14 November at 11.58 PM
Government Housing Assistance May Boost Some Cancer ScreeningReceipt of government housing assistance is associated with increased rates of breast cancer (BC) and colorectal cancer (CRC) screening, according to a study published online Nov. 8 in the American Journal of Preventive Medicine.Jordan Baeker Bispo, Ph.D., from the American Cancer Society in Atlanta, and colleagues used data from |
|
HealthDay
02 November at 03.32 PM
Moderate, Heavy Use of Chemical Hair Relaxer Linked to Uterine CancerAmong postmenopausal Black women, moderate and heavy use of chemical hair relaxers is associated with an increased risk for uterine cancer, according to a study published online in the upcoming Dec. 15 issue of Environmental Research.Kimberly A. Bertrand, Sc.D., M.P.H., from Slone Epidemiology Center at Boston University, and colleague |
Medical xPress
05 July at 07.10 AM
When it comes to male life expectancy, nature and nurture work togetherAlthough the simple biological fact (nature) of being born male increases boys' and men's overall health risks, the behavioral choices (nurture) they make are at least as important. This means that trans men and others who identify as men, while not biologically male, may also experience the behavioral disadvantages of being male. |
|
Medical xPress
05 July at 06.50 AM
Study explores the link between stock market fluctuations and emergency room visits in ChinaThe advent of computerized trading and fintech platforms has made investing in stocks easier and more accessible to individuals worldwide. This has led to an increase in stock market participation in many countries, including China. |
|
Medical xPress
30 June at 07.40 AM
Decision to offer sedation for often-painful IUD insertion is 'groundbreaking,' health experts sayIntrauterine devices (IUDs) are a highly effective and long-lasting form of birth control placed in the uterus. Research shows that many people who get IUDs experience moderate to intense pain during the insertion. But it wasn't until recently that providers began to acknowledge this and do something about it. |
|
HealthDay
27 June at 03.19 PM
Immunoglobulin Replacement Therapy Beneficial for Blood CancersImmunoglobulin replacement therapy (IgRT) is associated with reductions in hypogammaglobulinemia, infections, severe infections, and associated antimicrobial use among real-world patients with chronic lymphocytic leukemia (CLL) or non-Hodgkin lymphoma (NHL), according to a study published online June 21 in Blood Advances.Jacob D. Soum |
Medpage Today
26 June at 04.59 PM
When Was the Last Time You Really Talked With Your Patient?My 10 o'clock patient's name is Maria*. Her chart has three "health maintenance" flags that are bright red, indicating that she is more than 3 years overdue for a mammogram, more than 6 years overdue for a Pap smear, and has... |
|
Medpage Today
23 June at 09.21 PM
Novel Triple-Hormone Agonist Boosts Beta-Cell Function in T2DORLANDO -- An investigational triple-hormone receptor agonist improved metabolic profiles of people with obesity with or without type 2 diabetes, an exploratory biomarker analysis of a phase II trial found. After 36 weeks... |
|
|
Medpage Today
22 June at 06.00 PM
Fenofibrate Slows Diabetic Retinopathy ProgressionORLANDO -- The cholesterol drug fenofibrate reduced progression of early eye disease among diabetes patients, the LENS trial showed. The fibrate reduced progression of early diabetic retinopathy or maculopathy by a relative... |
|
Medpage Today
22 June at 06.00 PM
Preventing Surgical-Site Infections; Drugs Go Head to Head for Ischemic StrokeTTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... |
|
Medical xPress
22 June at 05.20 PM
Lawsuit could challenge trust in Ozempic and other popular weight loss drugsThe manufacturers of the most popular weight loss drugs are being challenged in court. |
|
HealthDay
21 June at 03.38 PM
Overall Prevalence of Being Up-to-Date With Lung Cancer Screening Is LowThe overall prevalence of up-to-date (UTD) lung cancer screening (LCS) was low in 2022, with prevalence increasing with age and number of comorbidities, according to a study published online June 10 in JAMA Internal Medicine.Priti Bandi, Ph.D., from the American Cancer Society in Atlanta, and colleagues estimated the contemporary preval |
Newsletter for Healtcare
Join over 1.2M subscribers and receive one weekly email.
